JOCERQ Trademark

Trademark Overview

On Monday, December 20, 2010, a trademark application was filed for JOCERQ with the United States Patent and Trademark Office. The USPTO has given the JOCERQ trademark a serial number of 85201866. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 28, 2014. This trademark is owned by Glaxo Group Limited. The JOCERQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
jocerq

General Information

Serial Number85201866
Word MarkJOCERQ
Filing DateMonday, December 20, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 28, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 29, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, July 28, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 28, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2013EXTENSION 5 GRANTED
Wednesday, December 11, 2013EXTENSION 5 FILED
Wednesday, December 11, 2013TEAS EXTENSION RECEIVED
Saturday, June 15, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 14, 2013EXTENSION 4 GRANTED
Tuesday, June 11, 2013EXTENSION 4 FILED
Tuesday, June 11, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 6, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 5, 2012EXTENSION 3 GRANTED
Monday, December 3, 2012EXTENSION 3 FILED
Monday, December 3, 2012TEAS EXTENSION RECEIVED
Saturday, July 7, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 6, 2012EXTENSION 2 GRANTED
Wednesday, June 13, 2012EXTENSION 2 FILED
Tuesday, July 3, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 13, 2012TEAS EXTENSION RECEIVED
Tuesday, December 20, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 16, 2011EXTENSION 1 GRANTED
Friday, December 16, 2011EXTENSION 1 FILED
Friday, December 16, 2011TEAS EXTENSION RECEIVED
Tuesday, June 21, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 26, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2011PUBLISHED FOR OPPOSITION
Monday, March 21, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 21, 2011ASSIGNED TO EXAMINER
Wednesday, December 29, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 23, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

jocerq pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological